Related Experiment Video

Updated: Sep 7, 2025

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

21.4K

NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022

William G Wierda1, Jennifer Brown2, Jeremy S Abramson3

  • 1The University of Texas MD Anderson Cancer Center.

Journal of the National Comprehensive Cancer Network : JNCCN
|June 17, 2022
PubMed

Insights

New targeted therapies offer chemotherapy-free options for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). Achieving undetectable minimal residual disease predicts better survival in patients on fixed-duration BCL-2 inhibitor treatment.

Area of Science:

  • Hematology
  • Oncology
  • Clinical Guidelines

Background:

  • The treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) has shifted towards targeted therapies.
  • Bruton's tyrosine kinase (BTK) inhibitors and BCL-2 inhibitors provide effective chemotherapy-free treatment options.

Purpose of the Study:

  • To discuss updates to the NCCN Guidelines for CLL/SLL.
  • Focus on chemotherapy-free treatment strategies for both treatment-naïve and relapsed/refractory CLL/SLL patients.

Main Methods:

  • Review of recent clinical advancements in CLL/SLL treatment.
  • Analysis of NCCN Guidelines pertaining to targeted therapies.
  • Evaluation of minimal residual disease (MRD) as a prognostic marker.

Main Results:

  • Targeted therapies (BTK and BCL-2 inhibitors) are now standard chemotherapy-free options.
  • Undetectable MRD post-treatment is a significant predictor of progression-free and overall survival.
  • NCCN Guidelines have been updated to reflect these changes.

Conclusions:

  • Chemotherapy-free targeted treatments represent a major advancement in CLL/SLL management.
  • Monitoring for undetectable MRD is crucial for assessing treatment efficacy and patient outcomes.
  • Updated NCCN Guidelines support the integration of these novel approaches.

More Related Videos

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

7.6K
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

13.8K

Related Concept Videos

Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
5.7K
Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
1.5K
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
3.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K